Zyla Health Expands in Southeast Asia, Empowering Patients with Personalised Digital Therapeutics
Hundreds of Southeast Asian doctors now prescribe Zyla's AI-based solution to hypertension, diabetes, dyslipidemia, chronic heart failure, and comorbid conditions patients. The outcome: enhanced healthcare results, higher patient activation, and a quantifiable change in everyday health habits.
Zyla's solution is designed specifically for globalisation. Its patient management system follows global coding standards like ICD-10, LOINC, ATC, and CPT to ensure easy integration with health systems globally. Its agentic AI-powered proprietary lifestyle intervention engine links diseases to nutritional and lifestyle interventions. This allows for quick and correct localisation for various geographies with a robust scientific core. Also, local care teams adapt the interventions to local languages, cultures, and habits of life, which makes them highly relevant and effective.
Zyla's digital therapy solution in global markets has been shown to exhibit high patient adherence and significant health outcomes. On average, onboarded patients spend 12 minutes per day actively interacting with the app, a testament to strong adoption and ongoing interaction. Interestingly, 75% of patients remain active with the platform into their second quarter of care, above even India's retention rates. In addition, 50%+ users have indicated significant symptom improvement, highlighting the power of Zyla's tailored, AI-driven model of care.
Khushboo Aggarwal, CEO of Zyla Health, said, 'Our mission is to deliver high-quality, personalised care to the farthest reaches of the globe. The initial success we have achieved in Southeast Asia demonstrates that with the right combination of technology, medical knowledge, and local customisation, we can facilitate meaningful and sustainable health outcomes worldwide. We are thrilled to now extend this revolutionary care model to even more parts of Southeast Asia.'
Patient Voices from the Philippines- Patients in the Philippines have shared encouraging feedback about their experience with Zyla:
'I am grateful for the time and support given to me, as I really needed someone to talk to about my health. I'm looking forward to the guidance I'll receive from Zyla. I also appreciate the app's response, which resolved my questions about basic health concerns.'
Zyla Health is India's highest-rated personalised healthcare management platform focused on improving health outcomes. Zyla Health enables care at scale for health insurers, pharma and large enterprises through the AI powered Zyla Health app (consistently rated 4.7+).
The care Zyla Health implements spans across medical, physical, and mental health needs, powered by a complete in-house team of doctors, nutritionists, psychologists and other specialists. The process begins with a detailed health risk assessment of the population, followed by personalised care journeys ranging from chronic disease management to wellness programs.
Note to the Reader: This article is part of Mint' promotional consumer connect initiative and is independently created by the brand. Mint assumes no editorial responsibility for the content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
2 days ago
- Indian Express
Indian study finds what makes thyroid cancer aggressive, recurrent and treatment-resistant: What this means for precision therapy
In a significant leap for cancer research and precision medicine, an Indian study has decoded the complex genetic architecture of thyroid cancer — one of the most common endocrine malignancies. Researchers from Tata Memorial Centre and the University of Delhi, South Campus, have shed new light on how thyroid cancer behaves in Indian patients, identifying novel risk genes and molecular subtypes that could revolutionise diagnosis and treatment. Published in 'JCO Global Oncology,' the research is spearheaded by graduate student Vaishakhi Trivedi under the mentorship of Dr Kumar Prabhash and Dr Amit Dutt. 'Our work not only adds data to global cancer databases —it also redefines what is known about thyroid cancer in the Indian population,' Dr Dutt said. The rogue gene in the most common thyroid cancer The study concerns papillary thyroid cancer (PTC), which accounts for 80-85 per cent of all thyroid cancer cases in India. This is considered treatable. The team analysed DNA from 100 Indian patients and found mutations in the DUOX2 gene found in nearly nine per cent of cases. 'This gene, previously known for its role in thyroid hormone production, now appears to be a genetic red flag for recurrence and poor prognosis. This is the first time DUOX2 has been implicated as a predisposing factor in PTC. It offers an opportunity for early detection and potentially life-saving interventions,' Dr Dutt said. Study uncovers two distinct molecular subtypes The study even identified two different subtypes associated with aggressive cancer and high recurrence. The BRAF-RAS-driven subtype makes up 62 per cent of cases and is identified by mutations that are often tied to more aggressive tumour behaviour. The iBR (Independent of BRAF-RAS) subtype is a newly-defined category. 'This group lacks traditional mutations but shows alarming signs of treatment resistance and high recurrence. It is marked by alterations in genes like SMAD4 and TG — a previously uncharted territory for thyroid oncologists,' said Dr Dutt. This dual classification signals a new era of care where treatments are tailored to the patient's genetic profile rather than a one-size-fits-all approach. Cracking the genetic code of an aggressive form of thyroid cancer While PTC is common and often curable, anaplastic thyroid cancer (ATC) is its deadly cousin — rare, fast-moving and resistant to nearly every treatment in the book. The research team examined 68 samples and found mutations in the THRA gene in 11 per cent of Indian patients. This is in sharp contrast to Caucasian datasets. 'THRA, a gene tied to thyroid hormone signalling, appears to be a key player in cellular plasticity or the process by which cancer cells morph, lose their identity and become more aggressive. THRA mutations are like flipping the switch. They make the cancer harder to kill but they also give us a target. That's a rare silver lining,' Dr Prabhash explained. What this means for Indian patients — and the world These findings offer practical methods of how thyroid cancers are diagnosed, treated and managed in Indian patients. 'Patients with DUOX2 mutations could be monitored proactively, much like BRCA testing in breast cancer. This may help in diagnosing aggressive PTC early and prevent a relapse,' Dr Dutt said. Researchers also added that therapies that restore THRA function may finally give ATC patients a fighting chance. 'We need a personalised roadmap for thyroid cancer. With the promise of advanced tools like CRISPR gene editing and small-molecule inhibitors, these discoveries could soon migrate from the lab bench to the bedside,' the researchers said. 'Genetic profiling should be as routine as a biopsy,' said Vaishakhi Trivedi. 'We have the science. Now we need the systems to support it.' Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More
Time of India
7 days ago
- Time of India
Vietnam warns of food supply disruptions as African swine fever spreads
Hanoi: African swine fever outbreaks are spreading in Vietnam, threatening to disrupt food supplies in the Southeast Asian country, the government warned on Friday. Vietnam has this year detected 514 outbreaks in 28 out of 34 cities and provinces nationwide, the government said in a statement, adding that the authorities have culled more than 30,000 infected pigs. "The risk of African swine fever is on a rising trend, negatively affecting the pig farming industry, food supplies and the environment," the government said. African swine fever has disrupted the global pork market for years. In the worst outbreak over 2018-19, about half the domestic pig population died in China, the world's biggest producer, causing losses estimated at over $100 billion. The recent outbreaks in Vietnam have prompted Prime Minister Pham Minh Chinh to send an urgent directive to provinces and government agencies this week to deploy measures to curb the disease. Vietnam in 2023 approved the domestic commercial use of its first home-grown African swine fever vaccines, but officials said the rate of vaccinated pigs remains low. "Only around 30% of the pigs in my province have been vaccinated," said an animal health official of Quang Ngai province, where infections have been reported over the past few weeks. "It's not clear why the rate is low - it could either be the issue of vaccine availability, efficiency or cost," said another provincial official, who declined to be named as the person is not authorised to speak to the media. The agriculture ministry's Department of Animal Health didn't respond to Reuters' request for comment. Calls to AVAC Vietnam JSC, the country's main African swine fever vaccine producer, went unanswered. AVAC said last month it had sold 3 million vaccine doses in the domestic market and exported 600,000 doses to the Philippines and Indonesia.
India.com
13-07-2025
- India.com
Bad news for ex Bangladesh PM Sheikh Hasina as her daughter Saima Wazed put on..., Yunus government accuses her of...
New Delhi: Saima Wazed, daughter of former Bangladesh Prime Minister Sheikh Haisna and the Regional Director for WHO South East Asia, has been sent on indefinite leave by the World Health Organisation (WHO). According to the reports, the move comes amid Bangladesh's interim government's claim that she was involved in corruption during Hasina's regime. Health Policy Watch reported that WHO Director General Tedros Ghebreyesus has circulated an email informing the staff that Wazed would be on leave from July 11. His email further said that Dr Catharina Boehme, WHO's assistant director-general, would replace Wazed in the UN health agency's South-East Asia Regional Office (SEARO). Saima Wazed: All You Need To Know Saima Wazed is the daughter of Bangladesh's former prime minister Sheikh Hasina. She was born 9 December 1972 She served as the South East Asian regional director for the World Health Organization from November 1, 2023 to July 11, 2025. Saima Wazed graduated from Barry University. She is a licensed school psychologist. Wazed organized the first South Asian conference on Autism in 2011 in Dhaka, Bangladesh. She is the chairperson of National Advisory Committee on Autism and Neurodevelopmental disorders. She campaigned for 'Comprehensive and Coordinated Efforts for the Management of Autism Spectrum Disorders' resolution at the World Health Assembly which adopted the resolution, Autism Speaks praised her for spearheading 'a truly global push for support for this resolution'. She had been drafted as a global autism advocate of World Health Organization's (WHO) 25-member Expert Advisory Panel on mental health for 4 years in 2014. In November, 2016, Wazed had been elected as chairperson of International Jury Board meeting of UNESCO for Digital Empowerment of Persons with Disabilities. In April 2017, Wazed was designated as WHO Champion for Autism' in South-East Asia. In July, 2017 she became the WHO's goodwill ambassador for autism in the South-East Asia Region. Since 2022, Wazed has been a member of the Commission for Universal Health convened by Chatham House and co-chaired by Helen Clark and Jakaya Kikwete. Charges Against Wazed Bangladesh Anti Corruption Commission (ACC) lodged cases against Wazed in connection with her academic qualification while seeking the high-profile job earlier this year. According to ACC's charges, Wazed used her mother's influence to achieve the position of the regional chief of the WHO. As per the report, she falsely stated she held an honorary position at Bangabandhu Sheikh Mujib Medical University, a claim the university has refuted. Wazed is also accused of being involved in extensive corruption during her mother's tenure as Bangladesh's leader. According to the ACC, she used her influence and connections to unlawfully obtain approximately $2.8 million from multiple banks, channeling the money through the Shuchona Foundation, an organization she formerly led.
